Skip to main content

Not investment advice.Read full disclaimer

ATBPF: Antibe Therapeutics Inc. Competitors & Peer Comparison | finqOS

Healthcare · Medical - Devices

52W Range

99thpctl

Volume

1.89×avg

Market Cap

11.43MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Continue with finqOS

Compare Antibe Therapeutics Inc. to its peers

Side-by-side valuation, growth, and profitability metrics against the closest competitors.

Start Free Trial→Sign In

14-day free trial · No credit card required

Antibe Therapeutics Inc.

ATBPFOther OTC·USD·Closed

Antibe Therapeutics Inc.

ATBPFOther OTC·USD·Closed

$0.22

−0.19%

$0.22

−$0.00 (0.19%)

52W Range

99thpctl

Volume

1.89×avg

Mkt Cap

11.43MUSD

P/E

-0.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings